ENDEFR
Home › India › ASPIRO PHARMA LIMITED

ASPIRO PHARMA LIMITED

Public Limited Company (Ltd) · MEDAK, India · LEI 335800VHCJW7RENDMG83
LEI active

Summary

ASPIRO PHARMA LIMITED is registered in India and entered in the “Companies Register (Ministry of Corporate Affairs)” under number U24100TG2014PLC092771. Its legal form is Public Limited Company (Ltd). According to GLEIF, its ultimate parent is HETERO LABS LIMITED (India), which is also its direct parent. That group has 5 subsidiaries with LEIs in 2 countries, 4 of them in India. The LEI was first issued on 22 Aug 2023 and the record was last updated on 25 Jun 2026; the next renewal is due by 21 Aug 2027.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formPublic Limited Company (Ltd)
RegisterCompanies Register (Ministry of Corporate Affairs) · Register website
Registration numberU24100TG2014PLC092771
Registration authorityMinistry of Corporate Affairs
JurisdictionIndia
Registered addressPLOT NO. 23, SURVEY NO.321,, BIOTECH PARK PHASE-III,, 502281 MEDAK, India
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)4 Feb 2014
LEI335800VHCJW7RENDMG83
LEI statusactive
LEI first issued22 Aug 2023
LEI record last updated25 Jun 2026
Next LEI renewal21 Aug 2027
Corroboration of the LEI recordfully corroborated

Group membership

HETERO LABS LIMITED India ultimate parent
ASPIRO PHARMA LIMITED this entity
View the whole group: 5 subsidiaries in 2 countries

Relationship to the parent

Direct parentUltimate parent
ParentHETERO LABS LIMITEDHETERO LABS LIMITED
Accounting period31 Mar 2024 to 30 Mar 202531 Mar 2024 to 30 Mar 2025
Evidenceconsolidated accountsconsolidated accounts
Corroborationfully corroboratedfully corroborated
Accounting standardother standardother standard
Relationship start4 Feb 20144 Feb 2014
Recorded at GLEIF since25 Jun 202625 Jun 2026
Last updated25 Jun 202625 Jun 2026
Record statuscurrentcurrent

Other subsidiaries of the same direct parent (4)